40874 Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices

DEPARTMENT OF JUSTICE The company plans to bulk prohibits the cultivation and manufacture the listed controlled distribution of marihuana except by Drug Enforcement Administration substances for distribution to its persons who are registered under the [Docket No. DEA–869] customers. CSA to do so for lawful purposes. In accordance with the purposes specified Brian S. Besser, Bulk Manufacturer of Controlled in 21 CFR 1301.33(a), DEA is providing Acting Assistant Administrator. Substances Application: AMPAC Fine notice that the entity identified below Chemicals, LLC [FR Doc. 2021–16137 Filed 7–28–21; 8:45 am] has applied for registration as a bulk BILLING CODE P manufacturer of schedule I controlled AGENCY: Drug Enforcement substances. In response, registered bulk Administration, Justice. manufacturers of the affected basic DEPARTMENT OF JUSTICE ACTION: Notice of application. class(es), and applicants therefor, may SUMMARY: AMPAC Fine Chemicals, LLC. Drug Enforcement Administration file written comments on or objections of the requested registration, as has applied to be registered as a bulk [Docket No. DEA–870] manufacturer of basic class(es) of provided in this notice. This notice does not constitute any evaluation or controlled substance(s). Refer to Bulk Manufacturer of Controlled determination of the merits of the Supplemental Information listed below Substances Application: Bulk application submitted. for further drug information. Manufacturer of Marihuana: Nusachi DATES: Registered bulk manufacturers of Labs, LLC. The applicant plans to manufacture the affected basic class(es), and bulk active pharmaceutical ingredients applicants therefore, may file written AGENCY: Drug Enforcement (APIs) for product development and comments on or objections to the Administration, Justice. distribution to DEA-registered issuance of the proposed registration on ACTION: Notice of application. researchers. If the application for registration is granted, the registrant or before September 27, 2021. Such SUMMARY: The Drug Enforcement persons may also file a written request would not be authorized to conduct Administration (DEA) is providing other activity under this registration for a hearing on the application on or notice of an application it has received before September 27, 2021. aside from those coincident activities from an entity applying to be registered specifically authorized by DEA ADDRESSES: Written comments should to manufacture in bulk basic class(es) of regulations. DEA will evaluate the be sent to: Drug Enforcement controlled substances listed in schedule application for registration as a bulk Administration, Attention: DEA Federal I. DEA intends to evaluate this and other manufacturer for compliance with all Register Representative/DPW, 8701 pending applications according to its applicable laws, treaties, and Morrissette Drive, Springfield, Virginia regulations governing the program of regulations and to ensure adequate 22152. growing marihuana for scientific and safeguards against diversion are in SUPPLEMENTARY INFORMATION: In medical research under DEA place. accordance with 21 CFR 1301.33(a), this registration. As this applicant has applied to is notice that on June 14, 2021, AMPAC DATES: Registered bulk manufacturers of become registered as a bulk Fine Chemicals, LLC., Highway 50 and the affected basic class(es), and manufacturer of marihuana, the Hazel Avenue, Rancho Cordova, applicants therefor, may file written application will be evaluated under the California 95670, applied to be comments on or objections to the criteria of 21 U.S.C. 823(a). DEA will registered as a bulk manufacturer of the issuance of the proposed registration on conduct this evaluation in the manner following basic class(es) of controlled or before September 27, 2021. described in the rule published at 85 FR substance(s): ADDRESSES: Written comments should 82333 on December 18, 2020, and be sent to: Drug Enforcement reflected in DEA regulations at 21 CFR Drug Administration, Attention: DEA Federal Controlled substance code Schedule part 1318. Register Representative/DPW 8701 In accordance with 21 CFR Norlevorphanol ...... 9634 I Morrissette Drive, Springfield, Virginia 1301.33(a), DEA is providing notice that Methylphenidate ...... 1724 II 22152. To ensure proper handling of on June 23, 2021, Nusachi Labs, LLC., Levomethorphan ...... 9210 II comments, please reference Docket 2909 Armory Drive, Nashville, Levorphanol ...... 9220 II No—DEA–870 in all correspondence, Tennessee 37204, applied to be Thebaine ...... 9333 II including attachments. registered as a bulk manufacturer of the Remifentanil ...... 9739 II Tapentadol ...... 9780 II SUPPLEMENTARY INFORMATION: The following basic class(es) of controlled Controlled Substances Act (CSA) substances:

Controlled substance Drug code Schedule

Marihuana ...... 7360 I Tetrahydrocannabinols ...... 7370 I

Brian S. Besser, Acting Assistant Administrator. [FR Doc. 2021–16141 Filed 7–28–21; 8:45 am] BILLING CODE P

VerDate Sep<11>2014 19:19 Jul 28, 2021 Jkt 253001 PO 00000 Frm 00073 Fmt 4703 Sfmt 9990 E:\FR\FM\29JYN1.SGM 29JYN1 jbell on DSKJLSW7X2PROD with NOTICES